Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatectomy | 19 | 2021 | 29 | 5.560 |
Why?
|
| Portal Vein | 15 | 2020 | 19 | 4.400 |
Why?
|
| Liver Neoplasms | 13 | 2021 | 47 | 4.330 |
Why?
|
| Liver | 9 | 2022 | 57 | 2.300 |
Why?
|
| Liver Regeneration | 9 | 2020 | 12 | 2.100 |
Why?
|
| Ligation | 11 | 2019 | 19 | 1.270 |
Why?
|
| Postoperative Complications | 9 | 2022 | 385 | 1.120 |
Why?
|
| Colorectal Neoplasms | 4 | 2019 | 48 | 1.110 |
Why?
|
| Cause of Death | 3 | 2017 | 32 | 0.980 |
Why?
|
| Embolization, Therapeutic | 4 | 2020 | 32 | 0.830 |
Why?
|
| Registries | 6 | 2019 | 88 | 0.810 |
Why?
|
| Laparoscopy | 2 | 2021 | 95 | 0.780 |
Why?
|
| Humans | 29 | 2024 | 12240 | 0.640 |
Why?
|
| Publication Bias | 1 | 2018 | 3 | 0.550 |
Why?
|
| Neuroendocrine Tumors | 4 | 2019 | 28 | 0.550 |
Why?
|
| Bibliometrics | 1 | 2018 | 10 | 0.550 |
Why?
|
| Retrospective Studies | 10 | 2021 | 1467 | 0.540 |
Why?
|
| Male | 20 | 2019 | 6815 | 0.520 |
Why?
|
| Treatment Outcome | 9 | 2021 | 1478 | 0.520 |
Why?
|
| Pancreatic Neoplasms | 4 | 2024 | 47 | 0.500 |
Why?
|
| Liver Diseases | 1 | 2017 | 15 | 0.490 |
Why?
|
| Therapies, Investigational | 1 | 2016 | 5 | 0.470 |
Why?
|
| Middle Aged | 14 | 2019 | 4043 | 0.450 |
Why?
|
| Female | 17 | 2019 | 6974 | 0.440 |
Why?
|
| Aged | 12 | 2019 | 4000 | 0.420 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 726 | 0.330 |
Why?
|
| Time Factors | 7 | 2019 | 695 | 0.310 |
Why?
|
| Intestinal Neoplasms | 2 | 2018 | 10 | 0.280 |
Why?
|
| Survival Rate | 4 | 2018 | 152 | 0.280 |
Why?
|
| Stomach Neoplasms | 2 | 2018 | 24 | 0.280 |
Why?
|
| Pancreas Transplantation | 2 | 2021 | 13 | 0.270 |
Why?
|
| Vascular Surgical Procedures | 2 | 2019 | 10 | 0.260 |
Why?
|
| Length of Stay | 2 | 2021 | 126 | 0.250 |
Why?
|
| Risk Assessment | 4 | 2019 | 295 | 0.240 |
Why?
|
| Liver Failure | 2 | 2017 | 6 | 0.240 |
Why?
|
| Risk Factors | 5 | 2019 | 1049 | 0.240 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 168 | 0.240 |
Why?
|
| Kidney Transplantation | 3 | 2012 | 51 | 0.220 |
Why?
|
| Philosophy, Medical | 1 | 2004 | 2 | 0.210 |
Why?
|
| Feasibility Studies | 2 | 2015 | 113 | 0.210 |
Why?
|
| Spirituality | 1 | 2004 | 29 | 0.210 |
Why?
|
| Switzerland | 2 | 2021 | 5 | 0.210 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2024 | 4 | 0.200 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 61 | 0.200 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2021 | 9 | 0.180 |
Why?
|
| Organ Transplantation | 1 | 2021 | 20 | 0.170 |
Why?
|
| Hospitals | 1 | 2021 | 68 | 0.170 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 31 | 0.170 |
Why?
|
| Prognosis | 3 | 2018 | 363 | 0.160 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2020 | 1 | 0.160 |
Why?
|
| Adult | 7 | 2019 | 3557 | 0.160 |
Why?
|
| Hospital Mortality | 3 | 2015 | 72 | 0.150 |
Why?
|
| Abdominal Neoplasms | 1 | 2019 | 11 | 0.140 |
Why?
|
| Gallium Radioisotopes | 1 | 2018 | 4 | 0.140 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 11 | 0.140 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 10 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 18 | 0.140 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2018 | 14 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 28 | 0.140 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 21 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 32 | 0.140 |
Why?
|
| Rats, Wistar | 1 | 2017 | 29 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2017 | 13 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 141 | 0.130 |
Why?
|
| Hyperplasia | 1 | 2017 | 12 | 0.130 |
Why?
|
| Hypoxia | 1 | 2017 | 14 | 0.120 |
Why?
|
| Graft Rejection | 2 | 2007 | 30 | 0.120 |
Why?
|
| Animals | 3 | 2017 | 2092 | 0.120 |
Why?
|
| Primary Graft Dysfunction | 1 | 2015 | 1 | 0.110 |
Why?
|
| Methyl Ethers | 1 | 2015 | 4 | 0.110 |
Why?
|
| Transplantation Conditioning | 1 | 2015 | 18 | 0.110 |
Why?
|
| Anesthetics, Intravenous | 1 | 2015 | 7 | 0.110 |
Why?
|
| Propofol | 1 | 2015 | 8 | 0.110 |
Why?
|
| Anesthetics, Inhalation | 1 | 2015 | 8 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2017 | 827 | 0.110 |
Why?
|
| Hypertrophy | 1 | 2015 | 10 | 0.110 |
Why?
|
| Liver Transplantation | 1 | 2015 | 30 | 0.110 |
Why?
|
| Safety | 1 | 2014 | 14 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 34 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2014 | 99 | 0.100 |
Why?
|
| Tissue and Organ Procurement | 2 | 2012 | 22 | 0.100 |
Why?
|
| Viscera | 1 | 2013 | 1 | 0.100 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2013 | 2 | 0.100 |
Why?
|
| Vascular Patency | 1 | 2013 | 8 | 0.100 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2013 | 6 | 0.100 |
Why?
|
| Renal Artery | 1 | 2013 | 4 | 0.100 |
Why?
|
| Aneurysm | 1 | 2013 | 10 | 0.100 |
Why?
|
| Stents | 1 | 2013 | 28 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2013 | 21 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2012 | 22 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 115 | 0.090 |
Why?
|
| Logistic Models | 1 | 2012 | 196 | 0.090 |
Why?
|
| Patient Selection | 1 | 2012 | 111 | 0.090 |
Why?
|
| Histocompatibility Testing | 1 | 2009 | 2 | 0.080 |
Why?
|
| HLA-C Antigens | 1 | 2009 | 4 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 61 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2007 | 2 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2007 | 9 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2007 | 14 | 0.070 |
Why?
|
| Organ Size | 2 | 2017 | 41 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2007 | 54 | 0.060 |
Why?
|
| HLA-DP Antigens | 1 | 2006 | 1 | 0.060 |
Why?
|
| Complement C4b | 1 | 2006 | 1 | 0.060 |
Why?
|
| Isoantibodies | 1 | 2006 | 6 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2006 | 27 | 0.060 |
Why?
|
| Religion and Medicine | 1 | 2004 | 12 | 0.050 |
Why?
|
| Anesthesia, Intravenous | 1 | 2024 | 2 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 281 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2024 | 13 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2022 | 11 | 0.050 |
Why?
|
| Consensus | 1 | 2022 | 47 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2021 | 42 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 2152 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2020 | 42 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 546 | 0.040 |
Why?
|
| Argentina | 1 | 2019 | 1 | 0.040 |
Why?
|
| Blood Coagulation Disorders | 1 | 2019 | 8 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2019 | 13 | 0.040 |
Why?
|
| Europe | 1 | 2019 | 21 | 0.040 |
Why?
|
| Digestive System Neoplasms | 1 | 2018 | 5 | 0.040 |
Why?
|
| Thymus Neoplasms | 1 | 2018 | 8 | 0.040 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2018 | 3 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 38 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 53 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2019 | 42 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 118 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 156 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 338 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2017 | 7 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2017 | 21 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2017 | 12 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 58 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 90 | 0.030 |
Why?
|
| Edema | 1 | 2017 | 15 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 56 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 59 | 0.030 |
Why?
|
| Models, Animal | 1 | 2017 | 74 | 0.030 |
Why?
|
| Rabbits | 1 | 2017 | 110 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 171 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 247 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 817 | 0.030 |
Why?
|
| Belgium | 1 | 2015 | 1 | 0.030 |
Why?
|
| Brazil | 1 | 2015 | 17 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2015 | 10 | 0.030 |
Why?
|
| United States | 1 | 2018 | 989 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 115 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 464 | 0.030 |
Why?
|
| Biomarkers | 1 | 2015 | 294 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2013 | 11 | 0.020 |
Why?
|
| Child | 1 | 2012 | 614 | 0.020 |
Why?
|
| Cold Ischemia | 1 | 2009 | 1 | 0.020 |
Why?
|
| Immunization | 1 | 2009 | 5 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2009 | 7 | 0.020 |
Why?
|
| Histocompatibility | 1 | 2007 | 2 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 15 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 93 | 0.020 |
Why?
|
| Wisconsin | 1 | 2006 | 1 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2006 | 4 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2006 | 12 | 0.010 |
Why?
|
| Atrophy | 1 | 2006 | 29 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 23 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 760 | 0.010 |
Why?
|